Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Palantir Bioceuticals Inc IFAN

Palantir Bioceuticals, Inc., formerly IFAN Financial, Inc., is a biopharmaceutical company offering holistic solutions to mental health illnesses. The Company uses psychedelic-assisted psychotherapy (PAP), supervised use of ketamine, 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, Lysergic acid diethylamide (LSD), and ibogaine as part of elaborated psychotherapy programs.


GREY:IFAN - Post by User

Bullboard Posts
Post by qualitystocks.neton Jan 02, 2015 8:57pm
57 Views
Post# 23281542

IFAN Financial, Inc. (IFAN) Enters $1 Million Private Placem

IFAN Financial, Inc. (IFAN) Enters $1 Million Private Placem
IFAN Financial, Inc. (IFAN) Enters $1 Million Private Placement Agreement
 
Today before the opening bell, IFAN Financial announced that it is selling $1 million of its common stock and warrants in a private placement agreement with an accredited investor. Taking place in various stages, the investor has begun to fund the first tranche in the amount of $150,000. The fifth and final tranche in the amount of $200,000 is expected by February 9, 2015.
 
Pursuant to the agreement, the investor has agreed to purchase approximately 3.7 million restricted common shares at a price of $0.27 per share, and an equal amount of warrants that are exercisable until the end of this year, at a price of $1 per warrant share. Together, the units provide for possible total gross proceeds of approximately $4.7 million.
 
According to the press release issued this morning, the company plans to use the proceeds of this private placement to complete development of the IFAN technology platforms and to begin the commercialization process.
 
For more information on IFAN Financial and its mobile payment technologies, visit www.ifanfinancial.com
 
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com
Bullboard Posts